Behind the case: How Finnegan helped Eli Lilly swerve a $176.5m patent headache

Counsel explain how they helped Eli Lilly overturn a damages award related to its migraine drug and why Supreme Court guidance proved useful
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: